A synthetic peptide for use as a blocking control in assays to test for specificity of LSM14 A antibody, Alternative Names: LSM14A control peptide, LSM14A antibody Blocking Peptide, Anti-LSM14A Blocking Peptide, Lsm14A Scd6 Homolog A Blocking Peptide, C19orf13 Blocking Peptide, DKFZP434D1335 Blocking Peptide, FAM61A Blocking Peptide, RAP55 Blocking Peptide, LSM14A, LSMA-14, LSMA 14, LSMA-14 Blocking Peptide, LSMA 14 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
LSM14A
(LSM14A, SCD6 Homolog A (LSM14A))
Hintergrund
Sm-like proteins were identified in a variety of organisms based on sequence homology with the Sm protein family. Sm-like proteins contain the Sm sequence motif, which consists of 2 regions separated by a linker of variable length that folds as a loop. The Sm-like proteins are thought to form a stable heteromer present in tri-snRNP particles, which are important for pre-mRNA splicing.